Qatari German Company for Medical Devices (Q.P.S.C.) (QSE:QGMD)

QSE:QGMD Income Statement

Financials in millions QAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	9.98	27.85	42.66	40.55	24.57
Revenue Growth (YoY)	-64.15%	-34.71%	5.18%	65.07%	201.13%
Cost of Revenue	15.01	18.99	28.84	30.92	18.62
Gross Profit	-5.02	8.86	13.82	9.64	5.95
Selling, General & Admin	5.36	4.62	5.84	10.35	4.55
Other Operating Expenses	-	-	-	-6.67	-3.46
Operating Expenses	55.18	9.96	11.26	3.68	6.58
Operating Income	-60.21	-1.11	2.55	5.96	-0.63
Interest Expense	-10.75	-2.7	-3.79	-4.74	-2.74
Other Non Operating Income (Expenses)	2.47	2.93	2.48	-0.04	-0.15
EBT Excluding Unusual Items	-68.49	-0.88	1.24	1.18	-3.51
Gain (Loss) on Sale of Assets	-	-	-	-	0.01
Asset Writedown	-	2.22	-	-	4.39
Pretax Income	-68.49	1.34	1.24	1.18	0.88
Net Income	-68.49	1.34	1.24	1.18	0.88
Net Income to Common	-68.49	1.34	1.24	1.18	0.88
Net Income Growth	-	7.39%	5.36%	33.55%	-
Shares Outstanding (Basic)	116	116	116	116	116
Shares Outstanding (Diluted)	116	116	116	116	116
EPS (Basic)	-0.59	0.01	0.01	0.01	0.01
EPS (Diluted)	-0.59	0.01	0.01	0.01	0.01
EPS Growth	-	7.38%	5.36%	33.55%	-
Free Cash Flow	1.02	-2.03	0.8	5.21	-16.62
Free Cash Flow Per Share	0.01	-0.02	0.01	0.04	-0.14
Gross Margin	-50.30%	31.81%	32.39%	23.77%	24.21%
Operating Margin	-603.00%	-3.97%	5.98%	14.70%	-2.55%
Profit Margin	-685.92%	4.80%	2.92%	2.91%	3.60%
Free Cash Flow Margin	10.23%	-7.28%	1.87%	12.84%	-67.63%
EBITDA	-55.68	4.24	7.97	11.37	4.85
EBITDA Margin	-	15.22%	18.69%	28.03%	19.73%
D&A For EBITDA	4.53	5.34	5.42	5.4	5.48
EBIT	-60.21	-1.11	2.55	5.96	-0.63
EBIT Margin	-	-3.97%	5.98%	14.70%	-2.55%
Advertising Expenses	-	-	0.27	0.26	0.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.